Brand profile · Medical and Diagnostic Laboratories

DatChem Pty Ltd

DatChem Pty Ltd runs a Medical and Diagnostic Laboratories operation from Brisbane, QLD. Ownership is privately held; it publishes at datchem.life. It holds one address on record, all in Australia. The record counts 7 people. Tagged data mining, pain and adhd. One Australian registration (ABN) is a confirmed match. The record links three similar brands, most of them in Internet & Technology.

Profile live Privately Held Founded 2019 1 entity ABN 1 office country
Registry verified · ABR

Key facts

Counted staff
7
self-reported 2–10 band
Founded
2019
7 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • DATCHEM PTY LTD

    ABN13637715729

    QLDHigh confidenceMatched on exact nameABR

Legal entities

DatChem Pty Ltd: 1 registry entityDatChem Pty Ltd is linked to 1 registry entity: DATCHEM PTY LTD (ABN 13637715729, candidate).DatChem Pty LtdDATCHEM PTY LTDABN 13637715729Candidate · High confidence
Show as table · DatChem Pty Ltd: 1 registry entity
DatChem Pty Ltd: 1 registry entity
DATCHEM PTY LTDABN 13637715729
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

DatChem has been established to commercialize DatChem-Breast and DatChem-Neuro. DatChem is the first technology to apply advanced data analytic techniques to patented applications of magnetic resonance spectroscopy. Importantly DatChem data is obtained on an installed MR scanner base and the data evaluated in the DatChem cloud.

The first product to market is DatChem-Breast, which can quantify the risk of a woman developing breast cancer by applying its unique intelligence to predictive chemical signatures. It is integrated with the routine breast MRI. A twelve year blinded clinic trial of over 400 women has shown the technology correctly predicted 32 out of 32 women who would develop a breast cancer two to six years ahead of current methods. The clinic trial documentation was submitted to the United States Food and Drug Administration in April 2025 and is pending approval. If approved, this technology will allow women to make informed decisions as to their treatment.

The next product to market will be DatChem-ADHD, which can provide the treating specialist with an objective diagnosis, identification of neurochemical pathways affected, and if and how the patient responds to therapy. A DatChem-ADHD test is provided at the same time as an MRI and will result in a neurochemical profile for each person. That profile will be compared to a clinical database of healthy brains and those with ADHD. The technology can be used to monitor response or lack thereof to therapy.

Pain, post-traumatic stress disorder (PTSD), and blast exposure each have a unique neurochemical profile and can be objectively diagnosed. Again, response or lack of response to therapy can be monitored. For front line defenders, the technology can be applied to monitor resilience during training and in action.

The technology for each of these applications has a granted patent or a PCT application pending. DatChem-Neuro is the only objective test available to date for each of these conditions.

Specialties

All 8 specialties
  • Magnetic Resonance
  • Data Mining
  • Tissue Chemistry
  • Breast Cancer
  • ADHD
  • PTSD
  • Blast Exposure
  • Pain

Related specialties

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUBrisbane , QLDPrimary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

3 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under DatChem Pty Ltd?

One Queensland entity on the ABR. DATCHEM PTY LTD (ABN 13 637 715 729), high confidence.

How many people work at DatChem Pty Ltd?

The record holds 7 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does DatChem Pty Ltd have offices?

One address on record, Australia only. Primary: Brisbane, QLD.

Has DatChem Pty Ltd raised funding?

None linked to this brand.

What does DatChem Pty Ltd list as its specialties?

Eight tags on the brand's own list, among them data mining, pain and adhd.

Which companies are listed alongside DatChem Pty Ltd?

Three peer profiles on record: HeartAI and Infensa Bioscience.

What is DatChem Pty Ltd's website?